de Geode Capital Management Utah Medical Products UTMD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 7.45 M | Vender |
108,048
-12,049
| -10% | -USD 801 k | ﹤0.01% | 2698 |
|
|
2026
Q1 | USD 7.45 M | Comprar |
120,097
+32,302
| +37% | +USD 2.04 M | ﹤0.01% | 2541 |
|
|
2025
Q4 | USD 4.91 M | Vender |
87,795
-2,166
| -2% | -USD 126 k | ﹤0.01% | 2785 |
|
|
2025
Q3 | USD 5.67 M | Vender |
89,961
-24,855
| -22% | -USD 1.47 M | ﹤0.01% | 2716 |
|
|
2025
Q2 | USD 6.54 M | Comprar |
114,816
+7,040
| +7% | +USD 383 k | ﹤0.01% | 2593 |
|
|
2025
Q1 | USD 6.04 M | Comprar |
107,776
+9,839
| +10% | +USD 589 k | ﹤0.01% | 2569 |
|
|
2024
Q4 | USD 6.02 M | Comprar |
97,937
+857
| +0.9% | +USD 55.4 k | ﹤0.01% | 2652 |
|
|
2024
Q3 | USD 6.5 M | Comprar |
97,080
+8,516
| +10% | +USD 578 k | ﹤0.01% | 2618 |
|
|
2024
Q2 | USD 5.92 M | Comprar |
88,564
+14,885
| +20% | +USD 1.01 M | ﹤0.01% | 2630 |
|
|
2024
Q1 | USD 5.24 M | Comprar |
73,679
+1,659
| +2% | +USD 124 k | ﹤0.01% | 2677 |
|
|
2023
Q4 | USD 6.07 M | Comprar |
72,020
+3,296
| +5% | +USD 273 k | ﹤0.01% | 2606 |
|
|
2023
Q3 | USD 5.91 M | Comprar |
68,724
+2,396
| +4% | +USD 221 k | ﹤0.01% | 2562 |
|
|
2023
Q2 | USD 6.18 M | Vender |
66,328
-5,083
| -7% | -USD 479 k | ﹤0.01% | 2577 |
|
|
2023
Q1 | USD 6.77 M | Comprar |
71,411
+1,085
| +2% | +USD 100 k | ﹤0.01% | 2490 |
|
|
2022
Q4 | USD 7.07 M | Comprar |
70,326
+547
| +0.8% | +USD 49.9 k | ﹤0.01% | 2473 |
|
|
2022
Q3 | USD 5.95 M | Comprar |
69,779
+1,715
| +3% | +USD 151 k | ﹤0.01% | 2578 |
|
|
2022
Q2 | USD 5.85 M | Comprar |
68,064
+9,216
| +16% | +USD 786 k | ﹤0.01% | 2617 |
|
|
2022
Q1 | USD 5.29 M | Comprar |
58,848
+2,082
| +4% | +USD 191 k | ﹤0.01% | 2768 |
|
|
2021
Q4 | USD 5.68 M | Comprar |
56,766
+588
| +1% | +USD 60 k | ﹤0.01% | 2831 |
|
|
2021
Q3 | USD 5.22 M | Vender |
56,178
-451
| -0.8% | -USD 39.8 k | ﹤0.01% | 2891 |
|
|
2021
Q2 | USD 4.82 M | Comprar |
56,629
+2,707
| +5% | +USD 234 k | ﹤0.01% | 2934 |
|
|
2021
Q1 | USD 4.67 M | Comprar |
53,922
+793
| +1% | +USD 69.7 k | ﹤0.01% | 2824 |
|
|
2020
Q4 | USD 4.48 M | Comprar |
53,129
+81
| +0.2% | +USD 6.9 k | ﹤0.01% | 2661 |
|
|
2020
Q3 | USD 4.24 M | Comprar |
53,048
+682
| +1% | +USD 56.6 k | ﹤0.01% | 2492 |
|
|
2020
Q2 | USD 4.64 M | Comprar |
52,366
+819
| +2% | +USD 73.5 k | ﹤0.01% | 2381 |
|
|
2020
Q1 | USD 4.85 M | Comprar |
51,547
+1,662
| +3% | +USD 154 k | ﹤0.01% | 2167 |
|
|
2019
Q4 | USD 5.38 M | Vender |
49,885
-507
| -1% | -USD 51.4 k | ﹤0.01% | 2408 |
|
|
2019
Q3 | USD 4.83 M | Vender |
50,392
-1,974
| -4% | -USD 183 k | ﹤0.01% | 2400 |
|
|
2019
Q2 | USD 5.01 M | Comprar |
52,366
+116
| +0.2% | +USD 9.8 k | ﹤0.01% | 2391 |
|
|
2019
Q1 | USD 4.61 M | Comprar |
52,250
+2,543
| +5% | +USD 224 k | ﹤0.01% | 2385 |
|
|
2018
Q4 | USD 4.13 M | Comprar |
49,707
+1,422
| +3% | +USD 125 k | ﹤0.01% | 2329 |
|
|
2018
Q3 | USD 4.55 M | Comprar |
48,285
+2,273
| +5% | +USD 217 k | ﹤0.01% | 2409 |
|
|
2018
Q2 | USD 5.07 M | Comprar |
46,012
+3,247
| +8% | +USD 339 k | ﹤0.01% | 2312 |
|
|
2018
Q1 | USD 4.23 M | Vender |
42,765
-6,419
| -13% | -USD 573 k | ﹤0.01% | 2343 |
|
|
2017
Q4 | USD 4 M | Comprar |
49,184
+3,849
| +8% | +USD 300 k | ﹤0.01% | 2333 |
|
|
2017
Q3 | USD 3.33 M | Comprar |
45,335
+3,118
| +7% | +USD 224 k | ﹤0.01% | 2447 |
|
|
2017
Q2 | USD 3.06 M | Comprar |
42,217
+4,740
| +13% | +USD 312 k | ﹤0.01% | 2476 |
|
|
2017
Q1 | USD 2.33 M | Comprar |
37,477
+1,550
| +4% | +USD 97.6 k | ﹤0.01% | 2579 |
|
|
2016
Q4 | USD 2.61 M | Comprar |
35,927
+597
| +2% | +USD 38.8 k | ﹤0.01% | 2475 |
|
|
2016
Q3 | USD 2.11 M | Vender |
35,330
-86
| -0.2% | -USD 5.47 k | ﹤0.01% | 2527 |
|
|
2016
Q2 | USD 2.23 M | Comprar |
35,416
+570
| +2% | +USD 36.8 k | ﹤0.01% | 2404 |
|
|
2016
Q1 | USD 2.18 M | Comprar |
34,846
+4,815
| +16% | +USD 284 k | ﹤0.01% | 2397 |
|
|
2015
Q4 | USD 1.76 M | Comprar |
30,031
+365
| +1% | +USD 20.7 k | ﹤0.01% | 2564 |
|
|
2015
Q3 | USD 1.6 M | Comprar |
29,666
+759
| +3% | +USD 41.4 k | ﹤0.01% | 2583 |
|
|
2015
Q2 | USD 1.72 M | Comprar |
28,907
+254
| +0.9% | +USD 14.3 k | ﹤0.01% | 2598 |
|
|
2015
Q1 | USD 1.72 M | Comprar |
28,653
+14,976
| +109% | +USD 880 k | ﹤0.01% | 2539 |
|
|
2014
Q4 | USD 821 k | Comprar |
13,677
+473
| +4% | +USD 26.2 k | ﹤0.01% | 2952 |
|
|
2014
Q3 | USD 643 k | Comprar |
13,204
+412
| +3% | +USD 20.9 k | ﹤0.01% | 3044 |
|
|
2014
Q2 | USD 658 k | Comprar |
12,792
+1,372
| +12% | +USD 70.4 k | ﹤0.01% | 3034 |
|
|
2014
Q1 | USD 660 k | Comprar |
11,420
+2,703
| +31% | +USD 147 k | ﹤0.01% | 3013 |
|
|
2013
Q4 | USD 498 k | Comprar |
8,717
+1,295
| +17% | +USD 71 k | ﹤0.01% | 3092 |
|
|
2013
Q3 | USD 441 k | Comprar |
7,422
+476
| +7% | +USD 26 k | ﹤0.01% | 3010 |
|
|
2013
Q2 | USD 377 k | Comprar |
+6,946
| Nuevas | +USD 327 k | ﹤0.01% | 3002 |
|
Otros fondos que tienen UTMD en su cartera
MA
Posición de Geode Capital Management en UTMD: resumen de T2 2026
Geode Capital Management redujo su participación en Utah Medical Products (UTMD) en 10% durante T2 2026, al vender acciones por un valor estimado de USD 801 k, y conservó 108,048 acciones valuadas en USD 7.45 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2698.
Geode Capital Management reportó por primera vez una posición en UTMD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank mantienen una posición en UTMD.
- Al cierre de T2 2026, Geode Capital Management tenía 108,048 acciones de Utah Medical Products con un valor de USD 7.45 M.
- Geode Capital Management vendió 12,049 acciones de Utah Medical Products en T2 2026, por un valor estimado de USD 801 k.
- Utah Medical Products representó ﹤0.01% de la cartera de Geode Capital Management en T2 2026 y fue su posición número 2698.
- Geode Capital Management reportó por primera vez una posición en Utah Medical Products en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank tenían Utah Medical Products en cartera.
Según el Informe 13F de Geode Capital Management correspondiente a T2 2026, presentado el 12 ago 2026.